Search
for
Sort by
Research 30 of 1000+
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- Safety of Human Papillomavirus Vaccines: A Review
- Safety of testosterone treatment in postmenopausal women
- Safety of dermatologic medications in pregnancy and lactation
- Safety and efficacy of topical minoxidil in the management of androgenetic alopecia
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
- Safety of testosterone use in women
- Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review
- Safety and Effectiveness of VYC-15L, a Hyaluronic Acid Filler for Lip and Perioral Enhancement: One-Year Results From a Randomized, Controlled Study
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Safety of High-Dose Vitamin A
- Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
- Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia
- Guidelines on the safety of light‐based home‐use hair removal devices from the European Society for Laser Dermatology
- Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study
- Safety concerns when using novel medications to treat alopecia
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Safety of treatment options for spondyloarthritis: a narrative review
- Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
- Safety and efficacy analysis of liposomal insulin-like growth factor-1 in a fluid gel formulation for hair-loss treatment in a hamster model
- Safety Profile for Microneedling: A Systematic Review
- Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss
- Safety of Platelet‐Rich Plasma Subepithelial Infusion for Vocal Fold Scar, Sulcus, and Atrophy
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis